Vertex Pharmaceuticals Incorporated (ETR:VX1)
378.90
-2.15 (-0.56%)
Jun 27, 2025, 5:35 PM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €99.97 billion as of June 27, 2025. Its market cap has decreased by -10.30% in one year.
Market Cap
99.97B
Enterprise Value
91.54B
Revenue
10.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
€378.90
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 99.97B, an increase of 135,209.71%. That is a compound annual growth rate of 23.68%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Siemens Healthineers AG | 52.28B |
Merck KGaA | 48.98B |
Bayer Aktiengesellschaft | 26.50B |
Fresenius SE & Co. KGaA | 23.99B |
Sartorius Aktiengesellschaft | 13.80B |
Fresenius Medical Care AG | 13.68B |
Carl Zeiss Meditec AG | 5.18B |
Fielmann Group AG | 4.53B |